Sichuan Deebio Pharmaceutical

Manufacturer

Warning letter

Headquarters

People's Republic of China

Sites

People's Republic of China

Issue date

5 Feb 2024

Issuing office

Center for Drug Evaluation and Research | CDER

Posted date

20 Feb 2024

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Products & Services

Drugs